This document is an excerpt from the EUR-Lex website
Document C:2020:263:TOC
Official Journal of the European Union, C 263, 11 August 2020
Official Journal of the European Union, C 263, 11 August 2020
Official Journal of the European Union, C 263, 11 August 2020
ISSN 1977-091X |
||
Official Journal of the European Union |
C 263 |
|
![]() |
||
English edition |
Information and Notices |
Volume 63 |
Contents |
page |
|
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2020/C 263/01 |
Non-opposition to a notified concentration (Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV) ( 1 ) |
1 |
2020/C 263/02 |
Non-opposition to a notified concentration (Case M.9889 – ERGO/SDHS/Taishan Property & Casualty Insurance) ( 1 ) |
2 |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2020/C 263/03 |
3 |
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2020/C 263/04 |
Prior notification of a concentration (Case M.9891 – Hayfin Capital Management/Frans Bonhomme Group) Candidate case for simplified procedure ( 1 ) |
4 |
|
OTHER ACTS |
|
|
European Commission |
|
2020/C 263/05 |
6 |
|
|
|
(1) Text with EEA relevance. |
EN |
|